EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)VergleichsstudieMultizentrische StudieRandomisierte kontrollierte Studie

Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial

Christian Gerges iD, Mitja Jevnikar, Philippe Brenot, Laurent Savale iD, Antoine Beurnier iD, Hélène Bouvaist iD, Olivier Sitbon iD, Elie Fadel iD, Athénaïs Boucly iD, Denis Chemla iD, Gérald Simonneau, Marc Humbert iD und 3 weitere

Circulation: Cardiovascular Interventions · 2025-02 · 18 (2)

DOI: 10.1161/circinterventions.124.014785 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Circulation: Cardiovascular Interventions, 2025-02. Verfasst von Christian Gerges und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria (C.G.). Hauptthemen laut MEDLINE: Angioplasty, Balloon, Antihypertensive Agents, Hypertension, Pulmonary, Pulmonary Embolism. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Riociguat and balloon pulmonary angioplasty (BPA) improve hemodynamics in inoperable chronic thromboembolic pulmonary hypertension. Importantly, comparative effects of riociguat and BPA on different components of right ventricular (RV) afterload and function remain not fully elucidated. METHODS: We conducted a post hoc analysis including patients from the RACE trial (Riociguat Versus Balloon Pulmonary Angioplasty in Non-Operable Chronic Thromboembolic Pulmonary Hypertension) with complete data for the primary end point assessment (49 riociguat and 51 BPA). Symptomatic patients with a residual pulmonary vascular resistance >4 WU received add-on riociguat after BPA (n=18) or add-on BPA after riociguat (n=36) and were included in an ancillary 26-week follow-up study with hemodynamic reassessment at week 52. RESULTS: Cardiac output, stroke volume, and RV afterload improved significantly with riociguat and BPA, and the relative changes in RV afterload from baseline to week 26 were more pronounced in the BPA group (all P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, BalloonAntihypertensive AgentsHypertension, PulmonaryPulmonary EmbolismPyrazolesPyrimidinesAgedFemaleHumansMaleMiddle AgedArterial PressureCardiac OutputChronic DiseasePulmonary ArteryRecovery of FunctionStroke VolumeTime FactorsTreatment OutcomeVascular ResistanceVentricular Function, Right

Stichwörter der Autor:innen

angioplasty, balloonhypertension, pulmonaryriociguatvascular resistanceventricular function, right

Substanzen

Antihypertensive AgentsPyrazolesPyrimidinesriociguat

Autor:innen und Institutionen

  • Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria (C.G.).
  • Assistance Publique-Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France (C.G., M.J., L.S., O.S., A. Boucly, G.S., M.H., D.M., X.J.).
  • Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France (C.G., M.J., P.B., L.S., A. Beurnier, O.S., E.F., A. Boucly, G.S., M.H., D.M., X.J.).
  • INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies, Hôpital Marie Lannelongue, Le Plessis-Robinson, France (M.J., P.B., L.S., A. Beurnier, O.S., E.F., A. Boucly, D.C., G.S., M.H., D.M., X.J.).
  • Service de Radiologie, Hôpital Marie Lannelongue, Le Plessis-Robinson, France (P.B.).
  • Assistance Publique-Hôpitaux de Paris, Service de Physiologie et Explorations Fonctionnelles Respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France (A. Beurnier, D.C.).

ORCID-Profile: Christian Gerges, Laurent Savale, Antoine Beurnier, Hélène Bouvaist, Olivier Sitbon, Elie Fadel, Athénaïs Boucly, Denis Chemla, Marc Humbert, David Montani, Xavier Jaïs

Zitieren

APA

Gerges, C., Jevnikar, M., Brenot, P., Savale, L., Beurnier, A., Bouvaist, H., Sitbon, O., Fadel, E., Boucly, A., Chemla, D., Simonneau, G., Humbert, M., Montani, D., Jaïs, X., & RACE Investigators (2025). Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial. Circulation: Cardiovascular Interventions, 18(2). https://doi.org/10.1161/circinterventions.124.014785

Vancouver

Gerges C, Jevnikar M, Brenot P, Savale L, Beurnier A, Bouvaist H, et al. Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial. Circulation: Cardiovascular Interventions. 2025;18(2). doi:10.1161/circinterventions.124.014785

BibTeX
@article{Gerges2025,
  author = {Gerges, Christian and Jevnikar, Mitja and Brenot, Philippe and Savale, Laurent and Beurnier, Antoine and Bouvaist, Hélène and Sitbon, Olivier and Fadel, Elie and Boucly, Athénaïs and Chemla, Denis and Simonneau, Gérald and Humbert, Marc and Montani, David and Jaïs, Xavier and RACE Investigators, RACE Investigators},
  title = {Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE Trial},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {2},
  doi = {10.1161/circinterventions.124.014785}
}
Kostenlos starten →